Suppression of the hypothalamic–pituitary–gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: Studies in human GnRH receptor knock-in mice
Nakata, Daisuke, Masaki, Tsuneo, Tanaka, Akira, Yoshimatsu, Mie, Akinaga, Yumiko, Asada, Mari, Sasada, Reiko, Takeyama, Michiyasu, Miwa, Kazuhiro, Watanabe, Tatsuya, Kusaka, Masami
Published in European journal of pharmacology (15.01.2014)
Published in European journal of pharmacology (15.01.2014)
Get full text
Journal Article
O2F-3-4 Inhibition of androgen synthesis by TAK-700, a 17, 20-lyase inhibitor
Masuo Yamaoka, Takahito Hara, Hiromi Shinohara, Tsuneo Masaki, Hideo Araki, Yumiko Akinaga, Takenori Hitaka, Nobuyuki Matsunaga, Tomohiro Kaku, Akihiro Tasaka, Masami Kusaka, Shuichi Furuya
Published in Journal of Pharmacological Sciences (2009)
Get full text
Published in Journal of Pharmacological Sciences (2009)
Journal Article
Pharmacologic profiles of investigational kisspeptin/metastin analogues, TAK-448 and TAK-683, in adult male rats in comparison to the GnRH analogue leuprolide
Matsui, Hisanori, Masaki, Tsuneo, Akinaga, Yumiko, Kiba, Atsushi, Takatsu, Yoshihiro, Nakata, Daisuke, Tanaka, Akira, Ban, Junko, Matsumoto, Shin-ichi, Kumano, Satoshi, Suzuki, Atsuko, Ikeda, Yukihiro, Yamaguchi, Masashi, Watanabe, Tatsuya, Ohtaki, Tetsuya, Kusaka, Masami
Published in European journal of pharmacology (15.07.2014)
Published in European journal of pharmacology (15.07.2014)
Get full text
Journal Article